Home Nucleus Pharmaceuticals South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032

Overview

The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is expected to reach a 252.39 USD Million by 2032 and is projected to grow at a CAGR of 15.91% from 2025 to 2032.

Revenue, 2024 (USD Million)
104.89
Forecast, 2032 (USD Million)
252.39
CAGR, 2024 - 2032
15.91%
Report Coverage
South Korea

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market 2018-2032 USD Million

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 104.89 USD Million
  • Projected Market Size (2032): 252.39 USD Million
  • CAGR (2025-2032): 15.91%

Key Findings of South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market

  • The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at 104.89 USD Million in 2024.
  • The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is likely to grow at a CAGR of 15.91% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 75.55 USD Million
  • The fastest growing segment Mechanical Ventilation in Type Segment grew Fastest with a CAGR of 16.79% during the forecast period from 2024 to 2032.

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
End User
  • Others
  • Home Healthcare
  • Specialty Clinics
  • Hospitals
Distribution Channel
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Direct Tender
Route of Administration
  • Others
  • Oral
  • Parenteral
Type
  • Others
  • Tocilizumab
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Antiviral Medication
  • Corticosteroids
  • Mechanical Ventilation
Cause
  • Others
  • Severe Pneumonia
  • Inhalation of Harmful Substances
  • Sepsis

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 104.89 USD Million
Market Value in 2032 252.39 USD Million
CAGR (2025-2032) 15.91%
Historic Data 2016-2023
Market Segments Covered End User,Distribution Channel,Route of Administration ,Type,Cause

Regional Insights:

  • Leading Market (2024-2032): South Korea, leading in terms of revenue 104.89 USD Million in 2024
    • Key Country: South Korea, leading in terms of revenue with value of 104.89 USD Million in 2024.

Segments and Scope

  • South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By End User
    • Hospitals is the largest segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 71.58 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.19 % in forecast period 2025-2032.
  • South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 58.14 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.71 % in forecast period 2025-2032.
  • South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Route of Administration
    • Parenteral is the largest segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 75.55 USD Million in the year 2024.
    • Parenteral is the Fastest growing segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.39 % in forecast period 2025-2032.
  • South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Type
    • Mechanical Ventilation is the largest segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 47.75 USD Million in the year 2024.
    • Mechanical Ventilation is the Fastest growing segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.79 % in forecast period 2025-2032.
  • South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Cause
    • Sepsis is the largest segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 59.66 USD Million in the year 2024.
    • Inhalation of Harmful Substances is the Fastest growing segment in South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.36 % in forecast period 2025-2032.

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis

 
Company Name Company Share Analysis
Medtronic
LivaNova
Terumo Corporation
Getinge AB
Gilead Sciences, Inc.
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration ,Type,Cause .
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 104.89(Revenue in USD Million) in 2021.
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 15.91% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market, holding a largest market share of 75.55 USD Million in 2024

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
End User
  • Others
  • Home Healthcare
  • Specialty Clinics
  • Hospitals
Distribution Channel
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Direct Tender
Route of Administration
  • Others
  • Oral
  • Parenteral
Type
  • Others
  • Tocilizumab
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Antiviral Medication
  • Corticosteroids
  • Mechanical Ventilation
Cause
  • Others
  • Severe Pneumonia
  • Inhalation of Harmful Substances
  • Sepsis
Frequently Asked Questions
The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration ,Type,Cause .
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 104.89(Revenue in USD Million) in 2021.
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 15.91% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 252.39 (USD Million).

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling

South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Frequently Asked Questions
The South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration ,Type,Cause .
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 104.89(Revenue in USD Million) in 2021.
South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 15.91% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 252.39 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES